Press Releases

Roche and Merck Establish Strategic Agreements in Fight Against Chronic Hepatitis C

Roche announced that it has entered into agreements with Merck, known as MSD outside the United States, through their respective subsidiaries, to improve the treatment, diagnosis and awareness of chronic hepatitis C (HCV) infection in the United States. The...

FDA approves linagliptin tablets for the treatment of type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes....

The American Society of Clinical Oncology and CollabRx Partner to Develop Online Apps for Planning Cancer Treatment

The American Society of Clinical Oncology (ASCO), the world's leading professional organization representing physicians who care for people with cancer, and CollabRx, an organization that leverages information technology to personalize cancer treatments and accelerate research have forged a strategic...

The European Commission Approves Pfizer’s Revatio for the Treatment of Pulmonary Arterial Hypertension in Children

Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or...

Almac Introduces selectAZyme

Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs of chiral intermediates for drug substance manufacture, regular enzyme supply to specialty chemical companies...

ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of Bepotastine Besilate Nasal Spray

ISTA Pharmaceuticals, Inc. announced positive, topline results from its Phase 2 dose-ranging, environmental clinical trial of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies....

Wockhardt receives US FDA approval for generic version of Aricept tablets

Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing 5mg and 10mg tablets of Donepezil HCl, which is used for treatment of Alzheimer’s disease and dementia. Donepezil...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read